Annual Report

Overview

The report describes the company's completed transformation into a patient-centric biopharmaceutical company in 2012, supported by growth in its core medicines and continued investment in its pipeline. It reports a worldwide workforce of 9 048 people across 70 nationalities. The CSR section sets out patient- and planet-centric initiatives, including energy, water, waste and workforce indicators. KPMG provided limited assurance over selected 2012 economic, environmental and social indicators.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2012
Period: Ends 31 December 2012
Publication date: 26 February 2013
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services